BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29060992)

  • 1. [A systematic review of international simulation models on the natural history of breast cancer: current understanding and challenges for Chinese-population-specific model development].
    Ma HM; Wang L; Shi JF; Ying JM; Zhu J; Chen LL; Yue XP; Gong JY; Li X; Wang JL; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Oct; 38(10):1419-1425. PubMed ID: 29060992
    [No Abstract]   [Full Text] [Related]  

  • 2. [A systematic review of worldwide natural history models of colorectal cancer: classification, transition rate and a recommendation for developing Chinese population-specific model].
    Li ZF; Huang HY; Shi JF; Guo CG; Zou SM; Liu CC; Wang Y; Wang L; Zhu SL; Wu SL; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):253-260. PubMed ID: 28231677
    [No Abstract]   [Full Text] [Related]  

  • 3. The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review.
    Poelhekken K; Lin Y; Greuter MJW; van der Vegt B; Dorrius M; de Bock GH
    Breast; 2023 Oct; 71():74-81. PubMed ID: 37541171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the impact of 25 years of DCIS treatment.
    Ozanne EM; Shieh Y; Barnes J; Bouzan C; Hwang ES; Esserman LJ
    Breast Cancer Res Treat; 2011 Aug; 129(1):165-73. PubMed ID: 21390494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
    Sanders ME; Schuyler PA; Dupont WD; Page DL
    Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients.
    Gregorowitsch ML; van den Bongard HJGD; Young-Afat DA; Pignol JP; van Gils CH; May AM; Verkooijen HM
    Breast Cancer Res Treat; 2018 Jan; 167(1):205-213. PubMed ID: 28894982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
    Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
    JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of ductal carcinoma in situ of the breast: a review.
    Erbas B; Provenzano E; Armes J; Gertig D
    Breast Cancer Res Treat; 2006 May; 97(2):135-44. PubMed ID: 16319971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study.
    Doebar SC; van den Broek EC; Koppert LB; Jager A; Baaijens MHA; Obdeijn IAM; van Deurzen CHM
    Breast Cancer Res Treat; 2016 Jul; 158(1):179-187. PubMed ID: 27318854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
    Knudsen ES; Ertel A; Davicioni E; Kline J; Schwartz GF; Witkiewicz AK
    Breast Cancer Res Treat; 2012 Jun; 133(3):1009-24. PubMed ID: 22134623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer.
    Mangé A; Lacombe J; Bascoul-Mollevi C; Jarlier M; Lamy PJ; Rouanet P; Maudelonde T; Solassol J
    Clin Cancer Res; 2012 Apr; 18(7):1992-2000. PubMed ID: 22322670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
    Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
    Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Natural history of breast cancer: a systematic review of worldwide randomized controlled trials of mammography screening].
    Yue XP; Shi JF; Mao AY; Wang L; Ma HM; Chen LL; Zhu J; Cheng X; Dai M
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):154-160. PubMed ID: 28219215
    [No Abstract]   [Full Text] [Related]  

  • 15. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical COX-2 overexpression correlates with HER-2/neu overexpression in invasive breast carcinomas: a pilot study.
    Çiriş IM; Bozkurt KK; Başpinar S; Kapucuoğlu FN
    Pathol Res Pract; 2011 Mar; 207(3):182-7. PubMed ID: 21371829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression Differences between Ductal Carcinoma in Situ with and without Progression to Invasive Breast Cancer.
    Doebar SC; Sieuwerts AM; de Weerd V; Stoop H; Martens JWM; van Deurzen CHM
    Am J Pathol; 2017 Jul; 187(7):1648-1655. PubMed ID: 28634007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analyses of key genes and pathways in the development of invasive breast cancer.
    Hou L; Chen M; Wang M; Cui X; Gao Y; Xing T; Li J; Deng S; Hu J; Yang H; Jiang J
    Gene; 2016 Nov; 593(1):1-12. PubMed ID: 27506314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection Rates of Ductal Carcinoma in Situ with Biennial Digital Mammography Screening: Radiologic Findings Support Pathologic Model of Tumor Progression.
    Weigel S; Khil L; Hense HW; Decker T; Wellmann J; Heidrich J; Sommer A; Heidinger O; Heindel W
    Radiology; 2018 Feb; 286(2):424-432. PubMed ID: 29106821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.